Monday, 18 June 2018

Hematological Malignancies Market to Reach a Value of US$ 51.9 Billion by 2024

The global hematological malignance market is highly competitive in nature with a large number of players operating in it worldwide, states a new research study by Transparency Market Research. In 2015, the leading four players in the market accounted for more than 58% share of the global market and is likely to remain in the similar leading position throughout the forecast period. To expand their product horizon, these players are focusing on extending their products and services in developing economies, which is likely to accelerate the growth of the overall market in the coming years. Some of the key players that are operating in the global hematological malignances market are Roche, Celgene, Novartis, and AbbVie, The rising number of mergers and acquisitions are estimated to encourage the growth of the overall market in the next few years.
As per the market research report by Transparency Market Research, in 2015, the global hematological malignance was worth US$27.4 bn. This market is likely to reach a value of US$51.9 bn by the end of 2024. The market is projected to register a healthy 7.50% CAGR between 2016 and 2024.
Among the key regional segments, North America is projected to experience a high growth throughout the forecast period. The increasing prevalence of hematological cancers and the advanced diagnostic technologies are some of the key factors that are estimated to encourage the growth of the North America market in the next few years. In addition to this, the presence of a large number of players is considered to generate promising growth opportunities in the coming years. This region is expected to be closely followed by Europe in the coming years, thanks to the increasing awareness among people regarding hematological malignance. Furthermore, Asia Pacific is estimated to witness significant growth throughout the forecast period.
Targeted therapy, immunotherapy, and chemotherapy are the major treatment methods in the global hematological malignances market. Among these segments, immunotherapy held a large share in 2015, and is expected to remain in the leading position throughout the forecast period. The high efficiency of immunotherapy and the less number of side effects are the key factors that are projected to accelerate the growth of this segment in the next few years.
The unhealthy and sedentary lifestyle of people worldwide resulting in a number of lifestyle-related disorders is considered as a major factor estimated to accelerate the growth of the global market in the next few years. The rising focus on research and development activities and innovations in the field of healthcare sector is projected to accelerate the growth of the global hematological malignances market in the coming few years. In addition to this, the rising awareness among consumers concerning the availability of advanced treatments is projected to generate promising growth opportunities for the market players in the next few years.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/4580
On the flip side, the high cost of branded drugs and the lack of favorable reimbursements policies are some of the key factors that are likely to restrict the overall growth of the global hematological malignances market in the coming few years.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at 7 comments:
Labels:

Bioremediation Technology & Services Market is Poised to Reach US$ 65.7 Billion by 2025

The presence of several established and emerging companies has rendered the vendor landscape in the global bioremediation technology and services market highly fragmented. However, some of the prominent players involved in the market are Altogen Labs, Aquatech International LLC, Drylet, LLC, InSitu Remediation Services Limited, Ivey International, Inc., PROBIOSPHERE Inc., REGENESIS, Sarva Bio Remed, LLC, Sevenson, Environmental Services, Inc., Soilutions Ltd, Sumas Remediation Services Inc., Xylem Inc., finds Transparency Market Research (TMR) in a recent study. These companies are adopting various strategies to strengthen their position, which are likely to have a profound impact on the prevailing market dynamics.
TMR has pegged the global bioremediation technology and services market at US$32.2 bn in 2016. Exhibiting an impressive 8.3% CAGR between 2017 and 2025, the market is poised to reach US$65.7 bn by the end of 2025. Regionally, North America marked dominance in the global market on the back of the presence of several companies offering bioremediation technologies and services. Furthermore, gaining strength from funding by local governments, the market in North America is likely to remain at the fore through the forecast period. Based on services, wastewater remediation services will witness the highest demand. The rising decentralized approached to treat wastewater streams is enabling growth in this segment.
The demand for bioremediation has escalated over the years in response to the surging contamination from waste. While several synthetic methods of treating wastewater have come into foray, the policymakers still seek more organic ways of achieving similar results. This has created an environment conducive to the market’s expansion in the coming years. Bioremediation implicates the use of organisms to neutralize or naturally remove waste contamination. The process breaks down hazardous substances into less toxic or nontoxic substances. Also, this is achieved in a method that does not use chemicals, therefore, enabling waste recycling ones contaminants are removed or neutralized.
The demand for bioremediation technology and services is likely to increase in the coming years in response to the rising awareness about the technology. Coupled with this, brooding water scarcity threats and government initiatives aimed at attaining environmental sustainability will enable growth in the market. In addition, the market is likely to gain pace due to the safety in operation bioremediation technologies offer, besides which cost-effectiveness and high efficiency of the process will enable the market gain momentum in the coming years.
On the downside, difficulties often linked to maintaining various technical factors in bioremediation could adversely influence the market’s prospects. Furthermore, the slower trajectory witnessed in emerging nations is a result of inadequate awareness. This, coupled with, high development cost make a key restraining factor, slowing down the market’s pace of gains to an extent. Nonetheless, stringent regulations imposed by governments to ensure environmental protection will stoke growth in the coming years. Furthermore, potential technological breakthroughs are likely to open immense growth prospects for the bioremediation technology and services market in the near future. Given the scenario, an increasing number of oil and gas companies are compelled to adopt bioremediation technologies and services to restore environment to its original state after frequent incidence of oil spills in oceans. Spurred by these factors, the global bioremediation technology and services market will exhibit robust growth in the coming years.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/37688
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at 6 comments:
Labels:

Image Guided Surgery Devices Market is expected to settle at a CAGR of 5.7% Between 2017 - 2025

The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing for business players. Several market players are already on the lookout for better business strategies to garner a global footprint. Moreover, the players are expected to focus on get into strategic alliances in order to attract a decent consumer base across the world. The major players identified by Transparency Market Research (TMR) include Koninklijke Philips N.V., Siemens Healthineers, Analogic Corporation, GE Healthcare, Stryker, Varian Medical Systems, Inc., Brainlab AG, Medtronic,KARL STORZ GmbH & Co. KG, and Olympus Corporation. The market strategies employed by these prominent players is anticipated to be a decisive standpoint for market progress.
Transparency Market Research (TMR) estimates that the market value is expected to stand at US$4,998.2 mn in 2025 as compared to a value of valuation of US$3,068.9 mn in 2016. Henceforth, the CAGR over the period from 2017 to 2025 is expected to settle at 5.7%. Based on application of these devices, neurosurgery is expected to be the leading category under the segment. This owes to the rising instance of neurological diseases and disorders across the globe. On a regional footing, North America is projected to reign over all other regions because of the increasing demand for non-invasive surgeries in the region.
The prime reason behind the adoption of guided surgery devices is their ability to excavate precise results. The medical fraternity is making fructuous efforts to ensure that surgeries are conducted with the aid of accurate information, which would in turn enhance the success rate. This has been a prudent factor driving the growth of the market worldwide. Moreover, the guided surgery devices have become the watchword for intricate surgeries because they these devices help the surgeons navigate through the process and plan better surgical operations. Patients have lately become immensely accepting of minimally invasive treatments which has led healthcare units to induct these devices within the framework. Chronic ailments such as cancer and osteoporosis have spread across a wider populace than before which makes it integral for the healthcare industry to have combat mechanisms. This is also an important pretext that is anticipated to bolster the market demand.
The geriatric population is prone to neurological disorders and suffers greater ailment during injuries. The low immunity makes it difficult for them recover from the side-effects of invasive treatments which calls for non-invasive treatment methods. The aforementioned factors play a vital role in enhancing the growth of the market. It is integral for various healthcare units tpo address the medical concerns of an increasing geriatric population by expanding the induction of guided surgery devices.
The lack of awareness with regards to the usage of these devices poses a threat to the growth of the market. Huge chunks of remote areas are still unexposed to the perks of these devices which not only shows the dismal picture in those regions but also points to the unexploited market potential. The costs of installing these devices is often beyond the affordability standards of healthcare units in developing countries. This also slacken progress. However, several government initiatives have surfaced across the world to strengthen the healthcare industry that shall be an important market booster.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/2541
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Friday, 15 June 2018

Pulmonary Function Testing Systems Market Competitive Landscape Analysis with Forecast by 2026

Global Pulmonary Function Testing Systems Market: Overview
The global market for pulmonary function testing systems is expected to expand at a boisterous rate over the forthcoming years. This stoked projection about the global market is based on the rising prevalence of respiratory diseases and the urgency to treat them. Pulmonary function testing is done to test the health of the lungs and to ensure that the respiratory tract of the body is free of infections. The process involves a systematic examination of the patient’s pulmonary health through chest x-rays, physical tests, arterial blood gas analysis, and a study of patient’s habits and health history. Pulmonary impairments can affect the normal functioning of life, and hence, it is important to limit their effect and severity. Doctors and medical experts recommend regular pulmonary function testing (PFT) for people of all age groups as it helps to stay in control of a person’s health. Furthermore, PFT is necessary for patients with existing lung dysfunction or past history of lung diseases. Owing to the aforementioned factors, the global market for pulmonary function testing (PFT) systems is projected to witness an upsurge in demand over the coming years.
The global market for pulmonary function testing systems can be segmented based on the following criteria: product type, applications, and region. All of the aforementioned parameters for segmentation are important for understanding the fettle of the global market.
A report on the global market for pulmonary function testing systems by TMR elucidates the drivers, restraints, and opportunities for market players. The report considers a range of market dynamics to draw inferences about the trends that are expected to surface over the coming years. The regional analysis of the market has also been included in the report for better understanding and comprehension.
Pulmonary Function Testing Systems Market: Trends and Opportunities
The respiratory system of a person is of utmost value for the normal functioning of life and the slightest of dysfunction in it can cause severe breathing issues. Hence, doctors and medical practitioners have been emphasizing on the need for regular pulmonary checkups of people of all age groups. This has given a push to the growth of the global market for pulmonary function testing systems and has created lucrative opportunities for market vendors. Furthermore, excessive consumption of tobacco in the form of cigarette smoking has increased the toll of people suffering from lung cancer. This has become the most prominent driver of demand within the global market for pulmonary function testing systems. Besides this, the growing geriatric population has also played a pivotal role in the rapid growth of the global market for pulmonary function testing systems.
Pulmonary Function Testing Systems Market: Regional Outlook
The need for pulmonary function testing is felt across all age groups but the aging population is at a greater risk of suffering from pulmonary disorders. Hence, increasing geriatric population in North America has driven demand within the regional market. Furthermore, the healthcare infrastructure across the region has gone from strength to strength, which has further fortified the market for pulmonary function testing systems across North America.
Pulmonary Function Testing Systems Market: Competitive Landscape
Minato, Schiller,MGC Diagnostics, COSMED, Morgan Scientific, Ganshorn, nSpire Health,
Sikeda, M&B, AESRI, NDD, CareFusion(BD), and RSDQ are amongst the key players in the global market for pulmonary function testing systems market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Foot and Ankle Plating System Market Current Trends and Future Aspect Analysis 2018 – 2026

In case of injury, trauma, or defect in the lower extremities of the body, i.e. the feet and ankles, special plates and screws are available for use to rectify and reconstruct them. Foot and ankle plating systems are implants that are placed inside the body to repair or reconstruct the damaged/injured parts. These systems are used to strengthen the ligaments and the tendons, or to attach them to the bone, or replace the bones, or hold the bones together. The foot and ankle area comprises the musculature, starting from the tibiofibular-talus joint or the ankle joint, and includes ligaments, muscles, and tendons, associated with the mid-foot, fore-foot, and hind-foot regions. Foot and ankle plating system is used to fix such parts, depending on the area of the injury.
The foot and ankle plating system market is fueled by the growing geriatric population, who are at a higher risk of bone injuries, rising prevalence of obesity, osteoarthritis, and osteoporosis, accidents, and youth-related sports injuries. Ankle and foot-joints issues can cause a lot of discomfort and pain to the patient and can significantly affect one’s lifestyle. Hence, it is essential that the foot and ankle implant plates are sturdy and implanted correctly. The foot and ankle plating system market is likely to be restrained due to factors such as high cost of the procedure and implants and post-operative infection caused by implant surgery.
The global foot and ankle plating system market can be segmented based on application, material, and end-user. In terms of application, the foot and ankle plating system market can be divided into total ankle replacement, ankle fusion, forefoot and midfoot fusion, subtalar fusion, and others. Total ankle replacements are expected to hold the leading share of the segment during the forecast period owing to rise in sports-related injuries and accidents. The ankle joint, being small, requires replacement, when broken. Based on material, the foot and ankle plating system market can be classified into stainless steel plates, titanium plates, composite plates, and others. Titanium plates are expected to hold a key share of the segment owing to their load-bearing capability and strength and lightweight. In terms of end-user, the foot and ankle plating system market can be categorized into hospitals, specialty clinics, and ambulatory surgical centers. Hospitals are expected to hold the dominant share of the segment owing to the focus of hospitals toward enhancing plating procedures to ensure reduced pain, improved mobility, and increased patient satisfaction. Emergence of new foot and ankle plating options and diverse plating options to treat different types of foot and ankle injuries is boosting the market.
In terms of region, the global foot and ankle plating system market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is expected to hold the leading market share during the forecast period owing to factors such as growing acceptance and adoption of foot and ankle implants and quick FDA approvals for such implants. For example, in February 2018, Centric Medical received FDA 510 clearance for its foot and ankle plating system. Europe is expected to hold the second dominant share of the foot and ankle plating system market. Rise in prevalence of obesity and technological advancements in the foot and ankle plating industry in Europe are boosting the growth of the market
Key players operating in the global foot and ankle plating system market include Paragon 28, Inc, Stryker, Wright Medical Group N.V., Medline Industries, Inc, CENTRIC MEDICAL, LLC, Acumed, VILEX IN TENNESSEE, INC., Orthofix Holdings, Inc., DePuy Synthes, Smith & Nephew, and Zimmer Biomet.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Veterinary Drugs Market to Exhibit a CAGR of 5.1% Between 2016 and 2024

The global veterinary drugs market is reasonably consolidated, with the top ten companies accounting for more than 70% of the overall market in 2015. Leading companies in the global veterinary drugs market include Merck Animal Health, Elanco Animal Health, Zoetis Inc., Bayer Animal Health, and Merial Animal Health. Fierce competition is the norm in the global veterinary drugs market due to the increasing commercial potential of the market and the lucrative opportunities on offer in developing regions, where specialty medical sectors such as the veterinary drugs market are yet to undergo smooth development and widespread adoption.
Many companies in the global veterinary drugs market are likely to focus on fostering closer relationships with individual customers in the coming years instead of developing a vast consumer base. This has emerged as a successful strategy in the global veterinary drugs market due to the intensifying competition; direct assistance is likely to remain a key tool in the repertoire of successful veterinary drugs market players in the coming years.
According to Transparency Market Research (TMR), the global veterinary drugs market is expected to exhibit a steady 5.1% CAGR from 2016 to 2024. The valuation of the veterinary drugs market is likely to rise from US$17.2 bn to US$26.7 bn over the timeframe.
The global veterinary drugs market is segmented into livestock animals and companion animals in terms of animal type. Of these, livestock animals are likely to remain the dominant consumers in the global veterinary drugs market due to the growing demand for high-quality protein and several other animal products. Rising meat consumption in new regional markets is likely to remain a key driver for the global veterinary drugs market over the 2016-2024 forecast period. Nevertheless, companion animals are also likely to account for a growing share in the global veterinary drugs market due to the rising demand for pet animals among urban consumers. The growing use of advanced pet care products in developing countries is likely to be a key driver for the global veterinary drugs market.
By product type, the global veterinary drugs market is segmented into anti-infective drugs, anti-inflammatory drugs, parasiticides, and others. Anti-infective drugs dominate demand from the global veterinary drugs market and are likely to remain the leading contributor to the global market over the coming years. However, parasiticides are likely to emerge with renewed importance in the global veterinary drugs market and are expected to exhibit a strong 6.1% CAGR from 2016 to 2024.
Regionally, North America is likely to remain the leading contributor to the global veterinary drugs market. This is mainly due to the widespread presence of veterinary drugs market players in the region, the growing popularity of a variety of companion animals, and the steady demand for a variety of meat and other animal products. The high disposable income of consumers in the region has also allowed for increased expenditure on animal care, which is likely to remain a key driver for the veterinary drugs market in North America. The North America accounted for more than 30% of the global veterinary drugs market in 2015 and is likely to retain a similarly dominant share through the 2016-2024 forecast period.
The rapid entry of new products in the veterinary drugs market has led to a risk of counterfeit products establishing dominant shares in the market. The increasing awareness about the adverse effects of some veterinary drugs on humans has also restricted the global veterinary drugs market in some regions.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/21152
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Hysteroscopes Market to Rise at a CAGR of 6.0% During the Period Between 2017 and 2025

Companies operating in the global hysteroscopes market are banking upon collaborations and co-development agreements to improve their positions. In response to the surging demand for minimally invasive techniques, they are coming up with HD optical lenses with increased resolution that are built from special sapphire glass for proper visualization. They are also seen launching hysteroscopes with semi-flexible shaft at lower cost to up sales.
Some of the prominent global participants in the global hysteroscopes market are MEDTRONIC, Olympus Corporation, Stryker, B. Braun Melsungen AG, and MedGyn Products, Inc. There are also many companies that have considerable presence in regional markets. Some of them are Richard Wolf Group, WISAP Medical Technology GmbH, LocaMed Limited, KARL STORZ GmbH & Co. KG, Maxer Medizintechnik GmbH, COMEG Medical Technologies (SOPRO-COMEG GmbH), and Optomic.
A report by Transparency Market Research predicts the global hysteroscopes market to rise at a CAGR of 6.0% during the period between 2017 and 2025 to become worth US$3.55 bn by 2025-end.
The two main types of application segments in the global hysteroscopes market are diagnostic hysteroscopy and surgical hysteroscopy.
The key geographical segments of the hysteroscopes market are Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America holds a dominant share in the market on the back of its state-of-the-art healthcare facilities available to the general public at affordable prices and substantial thrust on creating awareness about women’s health. The market in the region is expected to hold on to its dominant share going forward by registering a CAGR of 6.1% during the forecast period.
Hysteroscopes are minimally invasive gynecological procedures that help to diagnose the intrauterine infections and are also used for surgical interventions. They have become immensely popular due to their accuracy, convenience, and low cost. They primarily serve to treat dysfunctional bleeding, painful fibroids, and other women-centric health issues. “Hysteroscopy can be carried out in shorter time using a local anesthetic. At present, it is considered as a gold standard treatment for uterine intracavitary diseases. The thrust on designing more effective products with differentiated functionalities and features are projected to bolster growth in the global hysteroscopes market,” adds the lead analyst of the TMR report.
Both physicians and patients prefer hysteroscopy over traditional surgeries because of the excellent image brightness, ease of use, and greater stability they accord. Incisions are hardly required during the procedure and hence there is reduced post-operative discomfort. Such benefits have resulted in increasing adoption of hysteroscopes by gynecologists.
Hysteroscopes serve to reduce hospital stay by bringing about faster recovery, which in turn is due to the lowered blood loss and blood transfusion risks and lowered surgical site infections due to limited incisions. Growing knowledge about such advantages is stoking their popularity in market.
One challenge of the procedure is the complications regarding the proper entry of the device during surgical interventions. This, to an extent, is hampering demand, states the TMR report.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/28532
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Thursday, 14 June 2018

Ultrasonic Spirometers Market Latest Trends and Future Growth Study by 2026

Spirometer is an apparatus that measures the capacity of lungs. It is used to perform pulmonary function tests (PFT). The device specifically measures volume and speed (flow) of air inhaled and exhaled by lungs during breathing. Spirometers are helpful in assessing respiratory disorders such as asthma, emphysema, and bronchitis by inspecting ventilation i.e., obstructive and restrictive patterns of a lung. The airflow is measured by ultrasonic waves and Doppler effect technology. Recent advancements in sensor technology for ultrasonic spirometers enable the device to be optimized for home monitoring. Ultrasonic flow metering allows the manufacture of easy-to-use and low-maintenance spirometers.
Increase in preference for home-based diagnostic tools, efficient monitoring of pulmonary functions by ultrasound spirometers, and rise in prevalence of respiratory diseases such as asthma across the globe are likely to fuel the growth of the global ultrasonic spirometers market during the forecast period. However, lack of awareness about technological advancements in spirometers in developing countries and reimbursement issues for ultrasonic spirometers in some countries are projected to restrain the global ultrasonic spirometers market from 2018 to 2026.
The global ultrasound spirometers market can be segmented based on technology and end-user. In terms of technology, the global market can be classified into volume measurement, peak flow measurement, and flow measurement. The peak flow meters segment dominated the market in 2017 due to rise in prevalence of chronic obstructive pulmonary disorders (COPD) and aging global population. The segment is expected to continue to lead the market during the forecast period, owing to automatic internal calibration of ultrasonic spirometers and introduction of ultraviolet (UV) light assisted disinfection feature in the device by key manufacturers. However, rise in number of smokers across the globe and government participation in prevention & control of respiratory disorders are expected to propel the flow measurement segment from 2018 to 2026. In terms of end-user, the global ultrasonic spirometers market can be categorized into hospitals, clinics, home care settings, and others. The hospitals segment accounted for the largest market share in terms of revenue in 2017, attributed to rise in investment by public & private players for the betterment of healthcare sector in the developing countries, and favorable reimbursement policies. However, ultrasonic spirometers do not require daily external calibration, which is likely to propel usage in clinics and home care settings. Rise in number of patients with asthma and bronchitis owing to increasing air pollution is projected to boost the growth of the home care settings segment from 2018 to 2026.
Geographically, the global ultrasonic spirometers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share in 2017, attributed to increase in strategic operations of key manufacturers in the U.S. and Canada and rise in per capita expenditure of the population on health care. Emergence of local & regional manufacturers for ultrasonic spirometers in Europe is expected to augment the market in the region during the forecast period. However, Asia Pacific is projected to be the fastest growing market for ultrasound spirometers from 2018 to 2026, due to rise in adoption of digital connectivity in diagnostic equipment, cost-efficient design of ultrasonic spirometers, and efficient integration in hospital information systems.
Key players operating in the global ultrasonic spirometers market include Vitality Medical, ndd Medizintechnik AG, KWIPPED, Inc., Henry Schein, Inc., Meditech Equipment Co., Ltd., Schiller AG, Welch Allyn, GE Healthcare, Uscom Ltd., Contec Medical Systems Co., Ltd., and Midmark Corp. Introduction of advanced features such as wireless connectivity in ultrasonic spirometers is a key focus of the manufacturers to stay ahead of the competition.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Thin Film Drug Manufacturing Market is Rising at a Solid 9.0% CAGR Between 2016 and 2024

Competition is heating up in the global thin film drug manufacturing market owing to astute players betting big on new products by investing heavily in cutting edge research and development. Expanding of production facilities to satisfy the ever-surging global demand is another strategy being deployed by them.
To thrive in the challenging environment, players are also seen banking upon mergers and acquisitions to tap into the synergies. This is resulting in consolidation in the global market for thin film drug manufacturing. Indivior Plc., MonoSol Rx, IntelGenx Corp., and ZIM Laboratories Limited are to name a few companies that have reached a place of prominence by banking upon the aforementioned strategies.
A recent research study by Transparency Market Research finds that the global market for thin film drug manufacturing will likely become worth US$15.984 bn by 2024 by rising at a solid 9.0% CAGR between 2016 and 2024. It valued the market at US$7.338 bn in 2015.
Among the different types of thin film drug manufacturing, the oral thin film is expected to gross maximum revenue in the next few years. This is because of its myriad benefits such as ability to administer drugs via the oral mucosa, ease of handling and transportation, ability to eliminate the hepatic first pass effect, and early action. The segment is expected rise at a phenomenal two digit CAGR of 18.3% during the forecast period. From a geographical standpoint, North America, powered by the U.S. where superior pharmaceutical research and growing demand of novel drug delivery is maximum, leads the market. So much so, the U.S. held about 85.3% market share in 2016.
Developed European nations and the U.S. are at the forefront driving sales in the global market for thin film drugs on account of increased awareness about their solid efficiency in bringing about necessary therapeutic results and their ease of usage. Another reason why their demand in these nations is soaring is because of the absence of drawbacks of conventional forms of dosages in such novel products. Those include complicated administration and reduced bioavailability. On the contrary, they help administer appropriate dosages for the exact outcome. All such factors are catalyzing growth in the global market for thin film drug manufacturing. “Continued research and development, especially of innovative polymeric thin films, is also having a positive impact on the market,” adds the lead analyst of the report.
A trend observed in the market for thin film drug manufacturing is key players looking towards the under-tapped emerging markets, particularly in Asia Pacific. India, Japan, and China hold out a lot of promise and overall, the region is expected to be buoyed by unveiling of new products, rising awareness, and supportive regulations.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/11525
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Antimicrobial Ingredients Market is Poised to Expand at a CAGR of 4.1% Between 2017-2026

Improving the product safety is a top priority for participants in the global cosmetics industry. To ensure that their products are safe for human use, manufacturers of cosmetic products are using antimicrobial ingredients as additives in production techniques. Alcohols and other types of antimicrobial ingredients are being used in production of cosmetics, allowing the user to apply these products without being concerned about grave side-effects. Moreover, the role of antimicrobial ingredients in extending the product life is also supporting the robust end-use in the cosmetics landscape. Companies namely, Ashland Global Holdings Inc., BASF SE, Croda International Plc., Lonza Group Ltd., Clariant AG, The Dow Chemical Company, Solvay SA, Akzo Nobel N.V., Wacker Chemie AG, and Evonik Industries AG are expected to spearhead the global production of antimicrobial ingredients in the near future.
According to Transparency Market Research’s latest report, the global antimicrobial ingredients market is poised to register global sales of nearly 118,000 tons of antimicrobial ingredients by the end of forecast period, 2017-2026. During this period, the global market for antimicrobial ingredients is assessed to expand at a CAGR of 4.1% in terms of volume. The report has observed these companies as the key stakeholders in the global antimicrobial ingredients landscape.
Mexico and Brazil are among the leading producers of ingredients with antimicrobial properties. Relatively easy procurement of raw materials required to produce antimicrobial ingredients at a commercial scale continues to bolster Latin America’s antimicrobial ingredients market. In addition, low-wage skilled labor further aids the manufacturers, and increases the profit margins for players in the Latin American antimicrobial ingredients market. The report estimates that by the end of 2026, around 30% of antimicrobial ingredients produced in the world will translate into heavy revenues procured from Latin America. However, the report also projects that Europe and Asia-Pacific excluding Japan (APEJ) will represent fastest expansion by reflecting volume CAGRs above 5.5% during the forecast period.
The report has forecasted that by the end of 2026, antibacterial agents will emerge as the top-selling products in the global antimicrobial ingredients market. Increasing importance of protecting cosmetic products from common bacterial outgrowth will continue to fuel the demand for antibacterial agents in the global antimicrobial ingredients market. By the end of 2026, more than 32,000 tons of antibacterial agents are pegged to be sold globally. The report has also assessed a lucrative growth in demand for antifungal and anti-parasitic agents throughout the forecast period.
Majority of antimicrobial ingredients produced in the future will be used in manufacturing skin care products. By 2026-end, more than one-fourth of antimicrobial ingredients produced in the global market will be used in the production of skin care products. Hair care products is also expected to emerge as a key end-use of antimicrobial ingredients, and will register a volume CAGR of 4.2% over the forecast period. The report further estimates that antimicrobial ingredients will be predominantly manufactured in dry form over the foreseeable future. Limitations of liquid ingredients in terms of applications will continue to drive the scope for dry antimicrobial ingredients through 2026.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/39950
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Wearable Heart Monitoring Devices Market Share and Growth Factors Impact Analysis 2018 - 2026

A wearable heart rate monitor is a personal monitoring device. It enables real time measurement of heart rate. Wearable heart rate monitors are available in two forms: wrist bands and chest straps. These are especially designed to work in extreme conditions, and are compact and lightweight. Advanced models of heart rate monitors also provide activity, heart rate variation, breathing rate, and core temperature. The wrist band is a more popular heart rate monitoring device, as it provides comfort and is easy to use. However, it provides limited information as compared to chest strap. The accuracy of chest strap is higher as compared to the wrist watch. Wearable heart rate monitors are used by athletes and trainers to study and analyze their performance during sports activities. It is also used in hospitals for continuous monitoring of patients. Integration of technologies such as Bluetooth and Wi-Fi enable these devices to instantly transfer health information to computers or smartphones. This aids medical experts to analyze data quickly.
The global wearable heart monitoring devices market is expected to grow rapidly due to factors such as ease of use, low cost, rise in obesity among the population, and increase in awareness about fitness. Additionally, cardiac conditions such as atrial fibrillation (AFib) need continuous and extensive monitoring. According to the Centers for Disease Control and Prevention, 2.7 million to 6.1 million people in the U.S. suffered from AFib in 2017. Furthermore, it stated that over 750,000 people require hospitalization due to AFib in the country each year. The estimated medical cost for people suffering from AFib is about US$ 8,705 per person. Hence, rise in prevalence of atrial fibrillation along with increase in geriatric population and high per capita health care expenditure in the developed countries are projected to boost market growth during the forecast period. However, inconsistent and insufficient data is likely to hamper the growth of the global wearable heart monitoring devices market.
The global wearable heart monitoring devices market can be segmented based on product, type, application, end-user, and region. In terms of product, the global market can be classified into optical technology based, electric pulse based, and others. The optical technology based segment can be categorized into earphones, smart watches, and others. The electric pulse based segment can be divided into chest patches, chest straps, and others. Based on type, the global wearable heart monitoring devices market can be classified into Bluetooth enabled, chargeable, non-chargeable, and others. In terms of application, the global market can be categorized into health care, consumer market, and others. Based on end-user, the global wearable heart monitoring devices market can be divided into hospitals, retail pharmacies, academic institutes, and others.
Geographically, the global wearable heart monitoring devices market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region can be divided into specific countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC Countries. North America dominated the global wearable heart monitoring devices market because of high prevalence of AFib diseases and increase in health care expenditure. Moreover, presence of developed economies such as the U.S. and Canada and global players such as Medtronic and Briggs Healthcare fuel market growth. Asia Pacific is considered to be the most attractive market for wearable heart rate monitoring devices during the forecast period due to increase in health care expenditure and favorable government policies.
Key players operating in global wearable heart monitoring devices market are Kinetec Products UK Ltd., Medtronic, Beurer GmbH, Medisana AG, Briggs Healthcare, Polar Electro, SUUNTO, Koninklijke Philips N.V., and Garmin Ltd., among others.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Surgical Robotic Systems Market Competitive Landscape Analysis with Forecast by 2025

The growing trend of computer assisted or robotic minimally invasive surgery is expected to boost the growth of the market. Surgeons have adopted minimally invasive surgical (MIS) techniques for a wide range of applications such as cholecystectomy, appendectomy, prostatectomy, gastric bypass, ventral hernia repair, hysterectomy, colectomy, tubal ligation, and myomectomy. The number of cases of laparoscopic hysterectomy is projected to increase during the forecast period. About 96% of cholecystectomies is conducted laparoscopically. Hence, acceptance of and demand for surgical robots have risen in the last two decades. Surgical robots are medical devices that improve surgical outcomes by eliminating or reducing disadvantages in traditional surgery. Surgical robotic systems have been widely used for minimal invasive surgeries in specialties such as gynecology, cosmetology, open surgery, laparoscopic procedures, and flexible endoscopic procedures. These techniques cause minimal complications, reduce the risk of infections, cause less pain, and have faster recovery time which leads to shorter hospital stay in comparison with traditional therapies and treatments. These factors have helped in wide acceptance and adoption of surgical robotic systems by many medical facilities and centers.
The global surgical robotics systems market is driven by technological advancements in the health care industry, increase in geriatric population, and high prevalence of movement-restricting medical conditions. Surge in health care costs, lack of skilled health care personnel, and rise in cost of labor are also some of the factors that have led to demand for incorporation of lean operation methods in hospital management. However, high cost of surgical robots is a major factor restraining demand, especially in the developing markets.
The global surgical robotics systems market can be segmented based on product type, application, end-user, and region. In terms of product type, the global market can be classified into surgical systems, instrument & accessories, and services & maintenance. Based on application, the global surgical robotics systems market can be divided into orthopedic surgery, interventional cardiology, general surgery, neurological surgery, urological surgery, and others. Major surgical robots such as the da Vinci robotic system are the pioneers in the market. It was among the first robotic surgical systems to be introduced in the market. The device’s scope in performing a wide range of surgical procedures and established efficacy in performing such procedures are the major factors responsible for the rise in demand for these devices. By far, the da Vinci surgical system is viewed as the most versatile robotic surgical system available in the market, as it performs a wide range of surgical procedures. Constant innovation in the system and improvement in its operative efficiency have resulted into a feeling of trust among surgeons worldwide in installing this system in their facilities. Increase in the number of surgical procedures which could be performed via these systems is likely to propel the surgical robotic systems market.
Geographically, North America is the largest market for surgical robotic systems. Better reimbursement policies and existence of advanced health care infrastructure are the major drivers of the market in the region. The general population in North America is more aware about existence of health care robots and their added efficiency in surgical procedures and rehabilitation. The preference of medical practitioners for technologically advanced medical devices to enhance their productivity and eliminate redundant labor is high in North America. This is also propelling demand for medical robots in the region. On the other hand, improved health care infrastructure in the emerging economies in Asia Pacific, Latin America has given scope to establishment of new and more sophisticated healthcare facilities. This presents significant opportunity for the major players to introduce their robots in these regions.
Key players operating in the surgical robotic systems market are Intuitive Surgical, Inc., Accuray, Inc., Auris Surgical Robotics, TransEnterix, Inc., Think Surgical, Inc., Hansen Medical, Stryker Corporation, Smith & Nephew plc, Titan Medical Inc., and Zimmer Biomet Holdings, Inc.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Albumin Market to Become Worth US$ 10.359 Billion by 2025

The presence of scores of prominent companies focused on product extension and service expansion increasingly account for the intense competition in the global albumin market, finds Transparency Market Research (TMR). The strategic landscape is further likely to heat up with well-placed players seeking to consolidate their position by entering into collaborations and partnerships with various pharmaceutical and biotechnology companies in various parts of the world. They are also inclined to acquire distribution rights to expand their sales across various geographic regions, in order to get a firm foothold in the global market, notes TMR.
Top players operating in the global albumin market include MedxBio Pte. Ltd., Thermo Fisher Scientific Inc., InVitria, HiMedia Laboratories Pvt. Ltd., Mitsubishi Tanabe Pharma Corporation, Sigma-Aldrich Co. LLC., Octapharma AG, Grifols International, and CSL Behring LLC, S.A.,
The opportunities in the global albumin market is projected to surge from US$4.8 bn in 2016 to US$10.359 bn by 2025 end. The market is estimated to garner a healthy CAGR of 9.2% during 2017–2025.
The key varieties of albumin used are human serum albumin (HSA), bovine serum albumin, and recombinant albumin. Of these, HSA, the most widely found protein in human plasma, contributed the major share in the global market in 2016. The segment is expected to retain its dominance and will clock 9.2% CAGR during 2017–2025. The growth is driven by extensive application of HSA as blood volumizer helpful in a variety of conditions such as chronic diseases, rare blood conditions, and transfusion therapies.
Regionally, Asia Pacific presently holds the sway accounting for the leading share. The regional market is projected to expand at a promising CAGR of 11.5% from 2017 to 2025. The growth is fueled by substantially rising demand for albumin in emerging economies, notably India and China. This can be attributed to its potential application for treating rare diseases and burns.
Serum albumin, the most abundant protein found in blood plasma occupies a vital role in regulating blood volume by regulating colloid osmotic pressure and acts as carrier proteins for various molecules, including hormones, bile salts, and ions. This is a key factor promoting its use for blood volumizer in various conditions and in a range of replacement therapies.
The wide popularity of recombinant albumin for being used as pharmaceutical excipient is a notable factor accentuating the market. The substantial use of human serum albumin as an excipient for various biotechnology products is contributing to the attractive revenue in the market. Moreover, the market is benefitting from the use of albumin reagent in various life sciences procedures.
The rising instance of shocks, burns, and traumatic injuries among worldwide population is boosting the demand for albumin. The wide application of albumin in a variety hypovolemic conditions is a noteworthy factor boosting the market. Bovine serum albumin is the type derived from cows is frequently used a component of cell culture media, thereby accentuating the market’s growth. Its vast potential in protein chemistry research and cell culture media is catalyzing the growth of the overall market.
The rising volume of elderly population in a number of developing and developed countries is a notable factor boosting the market. The rapidly rise in incidence of rare diseases, such as rare blood conditions, is expected to favor the expansion of the demand for albumin. The rise in production of vaccine in various parts of the world and a notably rising demand for biologics in several developing and developed nations are notable factors contributing to the rapid expansion of the market.
Request TOC of the Report for Complete Review @ https://www.transparencymarketresearch.com/report-toc/3984
However, the growth of the albumin market is severely constrained by the lack of plasma fractionation in the pharmaceutical manufacturing industry and the emergence of viable alternatives for replacement therapies. Nevertheless, the market is expected to get a robust fillip from rising medical and clinical applications over the assessment period. Emerging, attractive prospects in this regard are medical imaging and nuclear medicine, expected to unlock promising prospects in the global market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)